Wyszukiwarka
The impact of mGlu2 or mGlu5 receptor activators on the production of l-arginine derivatives and the expression of PRMT5 or DDAH1 enzymes in animal models of cognitive decline
Abstrakt
L-arginine derivatives (ADMA, SDMA, NMMA) are endogenous inhibitors of nitric oxide (NO֗) production, which is essential in critical brain processes including blood-brain barrier (BBB) integrity and long-term potentiation (LTP). ADMA and NMMA are degraded by dimethylarginine dimethylaminohydrolase 1 (DDAH1) and protein arginine methyltransferase 5 (PRMT5) is an emerging epigenetic enzyme that mainly represses transcription of target genes via symmetric dimethylation of arginine residues. There is no data concerning the impact of metabotropic glutamate receptors (mGlu) ligands on this aspect of brain physiology. In the present studies the impact of positive allosteric modulators (PAM) of mGlu5 (CDPPB) and mGlu2 (LY487379) receptors on L-arginine derivatives, DDAH1 and PRMT5 expression in mouse models of cognitive dysfunction induced with MK-801(0.3 mg/kg) or scopolamine (1 mg/kg), was investigated. Experiments were performed both after acute and chronic (14 days) administration of the compounds, which were administered at the doses 0.1–5 mg/kg (CDBBB) and 0.1–1 mg/kg (LY487379). The chronic administration of both compounds normalized the level of L-arginine derivatives in MK-801 model (in brain and plasma) and only low dose of CDPPB prevented scopolamine-induced changes. The expression of DDAH1 and PRMT5 was modulated by CDPPB and LY487379, both in MK-801 and scopolamine models. In the novel object recognition (NOR) test low doses of the compounds, inactive after single administration, prevented cognitive decline after chronic injections. Our findings highlight the potential of mGlu receptor modulators in treating schizophrenia and possibly de-mentia by normalizing L-arginine derivatives production, preventing from nitric oxide synthases uncoupling.
Cytowania
-
0
CrossRef
-
0
Web of Science
-
0
Scopus
Autorzy (8)
-
Agata Płoska
-
Adrianna Radulska
-
Anna Siekierzycka
-
Paulina Cieślik
-
Michał Santocki
-
Iwona T. Dobrucki
-
Joanna M. Wierońska
Cytuj jako
Pełna treść
pełna treść publikacji nie jest dostępna w portalu
Słowa kluczowe
Informacje szczegółowe
- Kategoria:
- Publikacja w czasopiśmie
- Typ:
- artykuły w czasopismach
- Opublikowano w:
-
NITRIC OXIDE-BIOLOGY AND CHEMISTRY
nr 154,
strony 140 - 151,
ISSN: 1089-8603 - Język:
- polski
- Rok wydania:
- 2025
- Opis bibliograficzny:
- Płoska A., Radulska A., Siekierzycka A., Cieślik P., Santocki M., Dobrucki I. T., Kalinowski L., Wierońska J. M.: The impact of mGlu2 or mGlu5 receptor activators on the production of l-arginine derivatives and the expression of PRMT5 or DDAH1 enzymes in animal models of cognitive decline// NITRIC OXIDE-BIOLOGY AND CHEMISTRY -Vol. 154, (2025), s.140-151
- DOI:
- Cyfrowy identyfikator dokumentu elektronicznego (otwiera się w nowej karcie) 10.1016/j.niox.2024.11.010
- Źródła finansowania:
-
- This study was supported by the National Science Centre in Poland, grant no 2019/33/B/NZ7/02699 (OPUS 17 given to Joanna Wier-o´nska), and the Ministry of Education and Science grant no. 2/566516/ SPUB/SP/2023.
- Weryfikacja:
- Politechnika Gdańska
wyświetlono 0 razy
Publikacje, które mogą cię zainteresować
The Impact of LY487379 or CDPPB on eNOS Expression in the Mouse Brain and the Effect of Joint Administration of Compounds with NO• Releasers on MK-801- or Scopolamine-Driven Cognitive Dysfunction in Mice
- A. Płoska,
- A. Siekierzycka,
- P. Cieślik
- + 3 autorów
Procognitive activity of nitric oxide inhibitors and donors in animal models
- P. Cieślik,
- L. Kalinowski,
- J. M. Wierońska
Serotonergic–Muscarinic Interaction within the Prefrontal Cortex as a Novel Target to Reverse Schizophrenia-Related Cognitive Symptoms
- P. Cieślik,
- A. Radulska,
- G. Burnat
- + 2 autorów